Drug intelligence / Profile preview

99mTc-MAG3-BIIB067

Development stage
Unknown
Lead developer
Biogen
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intrathecal
01

Overview

99mTc-MAG3-BIIB067 is a radiolabeled version of tofersen (BIIB067), an antisense oligonucleotide that targets the SOD1 gene. It is used in clinical studies to evaluate the distribution of tofersen in the central nervous system (CNS). The compound consists of tofersen labeled with technetium-99m (99mTc) using MAG3 (mercaptoacetyltriglycine) as a chelating agent. This radiolabeled version allows for tracking the distribution of the drug using SPECT/CT imaging techniques.

02

Targets

SOD (Manganese Superoxide Dismutase)

Beyond the preview

Go deeper on 99mTc-MAG3-BIIB067.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 99mTc-MAG3-BIIB067.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call